Research Interests
The Ward Lab studies the role of cannabinoid, serotonin, and opioid receptor systems in pain and substance use disorders. Specifically, the team explores the therapeutic potential of cannabinoid-based compounds for neuropathic pain and addiction. Notably, Dr. Ward's lab was the first to demonstrate that cannabidiol (CBD), a plant-based cannabinoid, effectively prevents neuropathic pain and that combining CBD with tetrahydrocannabinol (THC) enhances this effect. Utilizing behavioral, molecular, and genetic approaches, their research further examines cannabinoid-opioid interactions to reduce pain and inflammation. The team’s groundbreaking findings have led to clinical trials with hemp-derived CBD for pain relief and are contributing to the development of future treatments for brain injuries and addiction.
Education, Training & Credentials
- PhD, Neuroscience, Wake Forest University School of Medicine, Winston-Salem, NC, 2004
- BA, Psychology, University of Connecticut, Storrs, CT, 1997